Rexsan Pharmaceuticals’ strategic goal is in line with its core value of developing pharmaceutical solutions that restore, renew and regulate key processes in the human body for optimal human well-being. To this end, we pursue a strategy of providing consumers with products that meet high standards of efficacy, quality and safety. This obliges us to take into account individual patient reactions to medicines and to ensure that the efficacy and safety of our products are monitored. To this end, the company has set up a pharmacovigilance system to collect and analyse data on the side effects of its products, to identify their causes, and to make adjustments to technologies and processes in order to minimise adverse effects and prevent future adverse effects.
You can report an adverse reaction to pharmaceutical products in the following ways: * by writing to us: info@rexsanpharma.lt * by directly filling in the online form in the Medicinal Products Information System of the State Medicines Control Authority under the Ministry of Health of the Republic of Lithuania https://vapris.vvkt.lt/vvkt-web/public/nrv
*by completing the Patient Report of Suspected Adverse Reaction (PRA) form available at https://www.vvkt.lt/index.php?4004286486 and sending it by e-mail (to NepageidaujamaR@vvkt.lt)
* by free phone at 8 800 73 568.
We would be very grateful if you could provide us with information about possible adverse reactions to our products. We will ensure that the information you provide is kept confidential and used only in accordance with legal requirements
